Costs, evidence, and value in the medicare program: The challenges of technology innovation in breast cancer prevention and control

2013-01-11

JAMA Internal Medicine , Volume 173 - Issue 3 p. 227- 228

Additional Metadata
Persistent URL	doi.org/10.1001/jamainternmed.2013.2127, hdl.handle.net/1765/56563
Journal	JAMA Internal Medicine
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Mandelblatt, J., Tosteson, A.& van Ravesteyn, N. (2013). Costs, evidence, and value in the medicare program: The challenges of technology innovation in breast cancer prevention and control. In JAMA Internal Medicine (Vol. 173, Number 3, pp. 227–228).https://doi.org/10.1001/jamainternmed.2013.2127

Publication